Erratum to: COXIBRAIN: results of the prospective, randomised, phase II/III study for the selective COX-2 inhibition in chronic subdural haematoma patients
Crossref DOI link: https://doi.org/10.1007/s00701-016-3016-9
Published Online: 2016-11-09
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schaumann, A.
Klene, W.
Rosenstengel, Chr.
Ringel, F.
Tüttenberg, J.
Vajkoczy, P.
License valid from 2016-11-09